Secukinumab and concomitant antibiotic use in patients with moderate-to-severe hidradenitis suppurativa: Week 16 efficacy and safety results from the Phase 3 SUNSHINE and SUNRISE trials

被引：0

作者：

Kokolakis, Georgios ^{[1
,2
,3
]}

Martorell, Antonio ^{[4
]}

Kerdel, Francisco ^{[5
]}

Bettoli, Vincenzo ^{[6
]}

Giamarellos-Bourboulis, Evangelos J. ^{[7
]}

Sinclair, Rodney ^{[8
]}

Kasparek, Torben ^{[9
]}

Li, Xianjun ^{[10
]}

Martinez, Angela Llobet ^{[9
]}

Uhlmann, Lorenz ^{[9
]}

Muscianisi, Elisa ^{[11
]}

机构：

[1] Charite Univ Med Berlin, Psoriasis Res & Treatment Ctr, Dept Dermatol Venereol & Allergol, Berlin, Germany

[2] Free Univ Berlin, Berlin, Germany

[3] Humboldt Univ, Berlin, Germany

[4] Hosp Manises, Dept Dermatol, Valencia, Spain

[5] Florida Acad Ctr Res & Educ, Coral Gables, FL USA

[6] Azienda Osped Univ Ferrara, Dept Oncol & Specialist Med, OU Dermatol, Ferrara, Italy

[7] Natl & Kapodistrian Univ Athens, Sch Med, Dept Internal Med 4, Athens, Greece

[8] Sinclair Dermatol, Melbourne, Vic, Australia

[9] Novartis Pharma AG, Basel, Switzerland

[10] Novartis Pharmaceut, Shanghai, Peoples R China

[11] Novartis Pharmaceut, E Hanover, NJ USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

42981

引用

页码：AB85 / AB85

页数：1

共 50 条

[1] Efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Final results from the Phase 3 SUNSHINE and SUNRISE trials
Kimball, Alexa B.
Jemec, Gregor B. E.
Alavi, Afsaneh
Reguiai, Ziad
Gottlieb, Alice
Wozniak, Magdalena B.
Uhlmann, Lorenz
Martinez, Angela Llobet
Field, Claire
Ravichandran, Shoba
Muscianisi, Elisa
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB156 - AB156
[2] Efficacy of secukinumab in patients with moderate-to-severe hidradenitis suppurativa previously treated with biologic therapy: Week 16 results from the SUNSHINE and SUNRISE trials
Zouboulis, Christos C.
Passeron, Thierry
Bastos, Pedro Mendes
Pariser, David
Offidani, Annamaria
Kasparek, Torben
Wozniak, Magdalena
Li, Xianjun
Uhlmann, Lorenz
Muscianisi, Elisa
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB160 - AB160
[3] Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial
Kimball, Alexa B.
Bechara, Falk G.
Badat, Aysha
Giamarellos-Bourboulis, Evangelos J.
Gottlieb, Alice B.
Jemec, Gregor B. E.
Reguiai, Ziad
Villani, Axel P.
Alarcon, Ivette
Bansal, Amita
Gasperoni, Francesca
Martin, Ruvie
Paguet, Bertrand
Uhlmann, Lorenz
Zouater, Hichem
Ravichandran, Shoba
Alavi, Afsaneh
BRITISH JOURNAL OF DERMATOLOGY, 2025, 192 (04) : 629 - 640
[4] Secukinumab in moderate to severe hidradenitis suppurativa: Week 16 results of hurley stage II and III from the sunshine and sunrise phase 3 randomized trials
Kimball, Alexa B.
Alavi, Afsaneh
Jemec, Gregor B. E.
Zouboulis, Christos C.
Wozniak, Magdalena B.
Uhlmann, Lorenz
Llobet-Martinez, Angela
Ravichandran, Shoba
Marzano, Angelo V.
Reguiai, Ziad
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 25 - 26
[5] Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials
Zouboulis, Christos C.
Passeron, Thierry
Pariser, David
Wozniak, Magdalena B.
Li, Xianjun
Uhlmann, Lorenz
Lobach, Iryna
Martinez, Angela Llobet
Ravichandran, Shoba
Alarcon, Ivette
Offidani, Annamaria
Alam, Maryam S.
Mendes-Bastos, Pedro
BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (06) : 836 - 845
[6] Secukinumab in moderate to severe hidradenitis suppurativa: Primary endpoint analysis from the SUNSHINE and SUNRISE Phase 3 trials
Gottlieb, Alice B.
Kimball, Alexa B.
Alavi, Afsaneh
Jemec, Gregor B. E.
Wei, Xiaoling
Wozniak, Magdalena B.
Uhlmann, Lorenz
Martinez, Angela Llobet
Keefe, Deborah
Martin, Ruvie
Chen, Li
Muscianisi, Elisa
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 25 - 26
[7] Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
Kimball, Alexa B.
Jemec, Gregor B. E.
Alavi, Afsaneh
Reguiai, Ziad
Gottlieb, Alice B.
Bechara, Falk G.
Paul, Carle
Bourboulis, Evangelos J. Giamarellos
Villani, Axel P.
Schwinn, Andreas
Rueff, Franziska
Ramaya, Larisha Pillay
Reich, Adam
Lobo, Ines
Sinclair, Rodney
Passeron, Thierry
Martorell, Antonio
Mendes-Bastos, Pedro
Kokolakis, Georgios
Becherel, Pierre-Andre
Wozniak, Magdalena B.
Martinez, Angela Llobet
Wei, Xiaoling
Uhlmann, Lorenz
Passera, Anna
Keefe, Deborah
Martin, Ruvie
Field, Clarice
Chen, Li
Vandemeulebroecke, Marc
Ravichandran, Shoba
Muscianisi, Elisa
LANCET, 2023, 401 (10378): : 747 - 761
[8] Secukinumab in moderate to severe hidradenitis suppurativa: Analysis of pooled data from the SUNSHINE and SUNRISE phase 3 randomized trials
Alavi, Afsaneh
Reguiai, Ziad
Jemec, Gregor B. E.
Gottlieb, Alice B.
Wozniak, Magdalena B.
Uhlmann, Lorenz
Fan, Heng
Llobet-Martinez, Angela
Ravichandran, Shoba
Kimball, Alexa B.
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 137 - 138
[9] Effect of secukinumab on draining tunnels in patients with moderate to severe hidradenitis suppurativa: Post hoc analysis of the SUNSHINE and SUNRISE phase 3 randomized trials
Bechara, Falk G.
Becherel, Pierre-Andre
Reguiai, Ziad
Mendes-Bastos, Pedro
Kirby, Joslyn S.
Hsiao, Jennifer
Bachhuber, Teresa
Wozniak, Magdalena B.
Kasparek, Torben
Ortmann, Christine-Elke
Lobach, Iryna
Field, Clarice
Ravichandran, Shoba
Kimball, Alexa B.
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 140 - 141
[10] Impact of secukinumab on the need for rescue surgical intervention in patients with moderate to severe hidradenitis suppurativa: Post-hoc analysis of week 16 data from sunshine and sunrise trials
van der Zee, Hessel H.
Szepietowski, Jacek C.
Sayed, Christopher
Guillem, Philippe
Hamzavi, Iltefat H.
Goldberg, Stephanie
Field, Clarice
Ortmann, Christine-Elke
Lobach, Iryna
Wozniak, Magdalena B.
Llobet-Martinez, Angela
Ravichandran, Shoba
Bachhuber, Teresa
Bechara, Falk G.
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 30 - 31

← 1 2 3 4 5 →